Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 22, 2026.

Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health

Ruixin Zhu, Ran Wang, Jingjing He and 12 more

JAMA Network Open · 2024

doi:10.1001/jamanetworkopen.2024.45309

Abstract

Importance Cardiovascular-kidney-metabolic (CKM) syndrome—a novel, multistage, multisystem disorder as defined by the American Heart Association—is highly prevalent in the US. However, the prevalence of CKM stages by social determinants of health (SDOH) remains unclear. Objective To investigate whether the prevalence of CKM stages varies by SDOH in US adults. Design, Setting, and Participants This cross-sectional study used data from the National Health and Nutrition Examination Survey (1999-2018) and included a nationally representative sample of adults aged 30 to 79 years through complex, multistage probability sampling. Data were analyzed from April 1 to June 15, 2024. Exposures The exposures included 5 CKM stages (ie, stages 0-4) reflecting progressive pathophysiology, with advanced (stages 3 or 4) and nonadvanced (stages 0, 1, or 2) disease. CKM stages were defined based on risk factors for metabolic syndrome, cardiovascular disease, and chronic kidney disease. Main Outcome and Measures The main outcome was the age-standardized prevalence of CKM stages and advanced CKM stages across SDOH, including education, marital status, family income, food security, health insurance, employment, home ownership, and health care access. Results Among 29 722 participants (weighted mean [SE] age, 50.8 [0.1] years; weighted 50.7% male), the age-standardized prevalence of CKM stages 0 to 4 was 13.6% (95% CI, 13.0%-14.3%), 29.9% (95% CI, 29.1%-30.7%), 43.7% (95% CI, 42.9%-44.5%), 4.7% (95% CI, 4.4%-5.0%), and 8.1% (95% CI, 7.6%-8.5%), respectively. Significant differences were observed in the prevalence of CKM stages across all unfavorable SDOH of interest compared with their favorable counterparts, with unemployment (18.8% [95% CI, 17.7%-20.1%] vs 11.4% [95% CI, 11.0%-11.9%]), low family income (16.1% [95% CI, 15.4%-16.8%] vs 10.1% [95% CI, 9.5%-10.7%]), and food insecurity (18.3% [95% CI, 17.1%-19.6%] vs 11.7% [95% CI, 11.2%-12.2%]) associated with an increased likelihood of advanced CKM stages. Participants with 2 or more unfavorable SDOH were more likely to have advanced CKM stages (age-standardized prevalence, 15.8% [95% CI, 15.2%-16.5%] vs 10.5% [95% CI, 9.9%-11.1%] with <2 unfavorable SDOH). Living in a rented home (15.9% [95% CI, 14.7%-17.0%] vs 9.3% [95% CI, 8.7%-9.9%] owning the home) or not living with a partner (13.2% [95% CI, 12.3%-14.3%] vs 9.2% [95% CI, 8.5%-9.8%] living with a partner) increased the likelihood of advanced CKM stages in female but not male participants. Conclusions and Relevance In this cross-sectional study, disparities in the prevalence of CKM stages by SDOH, particularly family income, food security, and employment, with notable sex differences, were observed in US adults. These findings highlight the need to address inequities in CKM syndrome through targeted interventions.

Shown for reading. Its publisher allows quoting it, not republishing it.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 22, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Cardiovascular-kidney-metabolic (CKM) syndrome, recently defined by the American Heart Association (AHA), describes the interplay among obesity, diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD). To capture the progressive nature of CKM syndrome, the AHA introduced a staging framework ranging from stages 0 to 4. Recent studies indicated that CKM syndrome is highly prevalent among US adults, with approximately 90% meeting the criteria for CKM stage 1 or higher between 2011 and 2020. Notably, 15% of US adults are classified as having advanced CKM stages (stages 3 or 4), with significant differences in prevalence based on sex and age. Specifically, men are more likely to have advanced CKM stages than women, while advanced CKM stages are more common in older adults (aged ≥65 years) than younger adults (aged 20-44 years).

Beyond age and sex, social determinants of health (SDOH), which are indicators of health equity, are associated with health outcomes. SDOH refer to nonmedical risk factors such as income, education, employment, housing, food security, and access to affordable health services. The US Healthy People 2030 initiative aims to achieve health equity and improve well-being through addressing SDOH. Previous studies have shown that SDOH significantly influence the development, diagnosis, and outcomes of the major components of CKM syndrome, such as diabetes, CKD, and CVD.,,,, Adverse SDOH have downstream consequences for events and mortality from diabetes, CKD, and CVD through behavioral pathways, such as physical inactivity and unhealthy diets.,,, Given the interconnected nature of obesity, diabetes, CKD, and CVD within CKM syndrome, adverse SDOH may contribute to the progression of CKM syndrome.

Identifying which SDOH require targeted attention might inform more effective screening and prevention strategies. However, the prevalence of CKM stages across various SDOH remains unclear. The aim of this study was to examine the prevalence of CKM stages 0 to 4 or advanced CKM stages (stages 3 or 4) by SDOH in a large, nationally representative sample of US adults. Additionally, we explored sex differences in the prevalence of advanced CKM stages by SDOH.

Study Population

This cross-sectional study used data from the National Health and Nutrition Examination Survey (NHANES), a serial, cross-sectional, national survey with a complex, stratified, multistage probability design. The NHANES protocol was approved by the National Center for Health Statistics Research Ethics Review Board. All participants or their guardian provided written informed consent prior to data collection. This study was exempt from review because it involved secondary data analysis of deidentified data, which poses minimal risk to participants’ privacy. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for cross-sectional studies.

The NHANES has been collecting nutritional and health information from a nationally representative sample of noninstitutionalized US adults and children every 2 years since 1999-2000 using a multistage, stratified sampling design. Response rates for NHANES participants have decreased over time from 76% in 1999-2000 to 49% in 2017-2018.

This study used data from 10 NHANES cycles (from 1999-2000 to 2017-2018). We excluded participants who were pregnant or lactating as well as those whose 10-year CVD risk could not be estimated using the AHA Predicting Risk of CVD Events (PREVENT) equations, which were used for the definition of CKM stages (ie, participants aged <30 years or >79 years or those with missing or extreme values of CVD risk factors) (eFigure 1 in Supplement 1). The final analytic sample comprised participants aged 30 to 79 years.

CKM Syndrome Stages

CKM syndrome stages (ie, stages 0-4) were defined based on the criteria from Aggarwal et al, with modifications for NHANES data. Briefly, participants were categorized by CKM stage as follows. Stage 0 included participants with a body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) of 18.5 to 24.9 and waist circumference of less than 88 cm for women or less than 102 cm for men who did not meet criteria for the other stages. Stage 1 included participants with a BMI of 25 or higher, a waist circumference of 88 cm or greater for females or 102 cm or greater for males, or prediabetes (fasting blood glucose of 100-124 mg/dL, glycosylated hemoglobin A1c of 5.7%-6.4%, or taking diabetes medications [to convert glucose to mmol/L, multiply by 0.0555; to convert hemoglobin A1c to proportion of total hemoglobin, multiply by 0.01]). Stage 2 included participants with metabolic risk factors (elevated fasting serum triglyceride levels ≥135 mg/dL [to convert to mmol/L, multiply by 0.0113], hypertension, diabetes, or metabolic syndrome) or moderate- to high-risk CKD according to Kidney Disease: Improving Global Outcomes criteria. Stage 3 included participants with very-high-risk CKD by Kidney Disease: Improving Global Outcomes criteria or a high predicted 10-year CVD risk. Stage 4 included participants with self-reported CVD (coronary heart disease, angina, heart attack, heart failure, or stroke). The 10-year CVD risk was estimated using the AHA PREVENT equations suitable for individuals aged 30 to 79 years. Participants were also classified into advanced (stages 3 or 4) or nonadvanced (stages 0, 1, or 2) CKM stages. High CVD risk was defined as a 10-year risk of at least 20% as estimated using the PREVENT equations. The CKD stages were classified based on estimated glomerular filtration rate (calculated using the race-free Chronic Kidney Disease Epidemiology Collaboration 2021 creatinine equation) and urinary albumin to creatinine ratio.

Social Determinants of Health

The SDOH of interest were dichotomized into favorable vs unfavorable conditions according to the conventional cut points: employment status (employed, student, or retired vs unemployed), family income to poverty ratio (≥300% vs <300%), food security (full security vs marginal, low, or very low security), education (high school graduate or higher vs less than high school), health care access (at least 1 regular health care facility vs none or emergency department), health insurance status (private vs government or no insurance), home ownership (own home vs rent home or other arrangement), and marital status (married or living with a partner vs not). Cumulative unfavorable SDOH were calculated based on the number of unfavorable SDOH domains (range, 0-8) and were dichotomized as 2 or more vs fewer than 2 (2 being the median value of the number of unfavorable SDOH domains).

Potential Confounders

Potential confounders, including age (continuous variable), sex (female or male), race and ethnicity (Mexican American; non-Hispanic Black, non-Hispanic White, and other [other Hispanic or other race, including multiracial and any race other than Black or White]), smoking status (current, former, or never smoker), alcohol consumption (nondrinker, <12 alcohol drinks per year; moderate drinker, ≥12 drinks per year but <1 drink per day for females or <2 drinks per day for males; heavy drinker, ≥1 drink per day for females or ≥2 drinks per day for males), and physical activity (active, ≥150 minutes per week of moderate-intensity activity or ≥75 minutes per week of vigorous-intensity activity; inactive, less than these thresholds) were collected during the household interview and self-reported by participants in each NHANES cycle using standard questionnaires. Race and ethnicity were self-identified by participants. For analytic purposes, other Hispanic and other races were combined due to their limited sample size. Dietary factors were excluded from the analysis due to prevalent misreporting of energy and nutrient intake in NHANES data.,

Statistical Analysis

Statistical analyses were performed using Stata, version 18.0 (StataCorp LLC) and SPSS, version 28.0 (IBM Corporation) from April 1 to June 15, 2024. Data were adjusted for the complex sampling survey design of NHANES, with strata, primary sampling units, and probability weights incorporated into statistical models using survey analysis procedures. Differences in baseline characteristics across the 5 CKM stages and between advanced (stages 3 or 4) and nonadvanced (stages 0, 1, or 2) CKM stages were assessed using survey-weighted linear regression for continuous variables and survey-weighted Pearson χ2 tests for categorical variables.

For the main analyses, data from NHANES 1999-2018 and 20-year sampling weights of 10 survey cycles were used. Age-standardized CKM prevalence rates were calculated by the direct standardization method with 3 age categories, including 30 to 44 years, 45 to 64 years, and 65 to 79 years, as in:where ri is the rate in age group i in the population of interest, pi is the standard population in age group i, P is ∑ni = 1, and n is the total number of age groups over the age range of the age-adjusted rate.

The 2010 US census population was selected as a standard population., The 95% CIs were estimated using Taylor series linearization.

Differences in the prevalence of CKM stages across age groups, sexes, races and ethnicities, and SDOH were determined using survey-weighted and age-standardized Pearson χ2 test. Survey-weighted multinomial logistic regression models, adjusted for baseline age, sex, race and ethnicity, alcohol consumption, smoking status, and physical activity, were used to estimate relative risk ratios (RRRs) and 95% CIs for the associations between SDOH and the prevalence of CKM stages. The multinomial logistic regression model was chosen over the ordinal logistic model due to the violation of the proportional odds assumption (ie, the hypothesis of parallel lines was rejected). Survey-weighted modified Poisson regression models,,, adjusted for the aforementioned confounders, were used to examine the associations between SDOH and the prevalence of CKM stages and to estimate prevalence ratios (PRs) and corresponding 95% CIs in all participants, in men only, and in women only. The χ2 automatic interaction detection classification tree was used for estimation of CKM stages or advanced vs nonadvanced CKM stages based on multiple SDOH. Sensitivity analyses were conducted using NHANES 2011-2018 data by replicating the main analyses for participants with advanced vs nonadvanced CKM stages.

As the PREVENT equations were not applicable to the imputed data, data imputation was not performed. Given the cross-sectional and exploratory nature of this study, which was designed to generate rather than test hypotheses, adjustments for multiple comparisons were not applied.,, Our results should be interpreted as exploratory due to the potential for type I error. A 2-sided P <.05 was considered statistically significant.

Participant Characteristics

This study analyzed data from 29 722 participants, with a weighted mean (SE) age of 50.8 (0.1) years. Among them, a weighted 49.3% were female and 50.7% male, and 7.5% self-reported as Mexican American, 12.3% as non-Hispanic Black, 70.9% as non-Hispanic White, and 9.3% as other race and ethnicity. Participants with advanced CKM stages were more likely to be older, male, smokers, nondrinkers, and physically inactive and to have unfavorable SDOH (Table 1).

Prevalence of CKM Stages by SDOH

The age-standardized prevalence of CKM stages 0, 1, 2, 3, and 4 was 13.6% (95% CI, 13.0%-14.3%), 29.9% (95% CI, 29.1%-30.7%), 43.7% (95% CI, 42.9%-44.5%), 4.7% (95% CI, 4.4%-5.0%), and 8.1% (95% CI, 7.6%-8.5%), respectively (Table 2). Significant differences in the prevalence of CKM stages were observed across age groups, sexes, and SDOH.

Participants with a lower education level had significantly higher RRRs for CKM stage 2 (1.38 [95% CI, 1.18-1.61]), stage 3 (1.44 [95% CI, 1.12-1.85]), and stage 4 (1.97 [95% CI, 1.63-2.38]) compared with those with a higher education level (Table 3). Similar trends were seen in family income to poverty ratio (<300% vs ≥300%), food insecurity vs full food security, unemployment vs employment, and without vs with home ownership. In contrast, participants with no regular care or only emergency department access had lower RRRs for advanced CKM stages (stage 3: 0.61 [95% CI, 0.40-0.94]; stage 4: 0.32 [95% CI, 0.23-0.46]) compared with those with access to at least 1 regular health care facility.

Prevalence of Advanced CKM Stages by SDOH

A higher prevalence of advanced CKM stages was observed among participants, compared with their counterparts, who were unmarried or not living with a partner (age-standardized prevalence, 14.2% [95% CI, 13.5%-15.0%] vs 12.2% [95% CI, 11.7%-12.8%]), had a family income to poverty ratio less than 300% (16.1% [95% CI, 15.4%-16.8%] vs 10.1% [95% CI, 9.5%-10.7%]), had food insecurity (18.3% [95% CI, 17.1%-19.6%] vs 11.7% [95% CI, 11.2%-12.2%]), had government health insurance or lacked health insurance (16.5% [95% CI, 15.7%-17.4%] vs 11.0% [95% CI, 10.5%-11.6%]), were unemployed (18.8% [95% CI, 17.7%-20.1%] vs 11.4% [95% CI, 11.0%-11.9%]), had a lower education level (17.3% [95% CI, 16.4%-18.3%] vs 11.8% [95% CI, 11.3%-12.4%]), and lived in a rented home (16.1% [95% CI, 15.2%-16.9%] vs 11.9% [95% CI, 11.4%-12.4%]) (Figure 1). Participants with 2 or more cumulative unfavorable SDOH had a higher prevalence of advanced CKM stages (15.8% [95% CI, 15.2%-16.5%] vs 10.5% [95% CI, 9.9%-11.1%] with <2 unfavorable SDOH; adjusted PR, 1.36 [95% CI, 1.26-1.46]). In contrast, participants with no regular health care or who used emergency departments were less likely to have advanced CKM stages compared with those with access to at least 1 regular health care facility (7.6% [95% CI, 6.6%-8.7%] vs (13.2% [95% CI, 12.7%-13.7%]). These findings remained robust in the sensitivity analyses except for education (eFigure 2 in Supplement 1). Decision trees indicated that employment status, health insurance, and family income to poverty ratio were key SDOH influencing CKM stage risk (eFigure 3 in Supplement 1).

Both men and women with unfavorable education, family income to poverty ratio, food security, health insurance, and employment status were more likely to have a higher prevalence of advanced CKM stages (Figure 2). Among women, those who were unmarried or not living with a partner (13.2% [95% CI, 12.3%-14.3%] vs 9.2% [95% CI, 8.5%-9.8%] married or living with a partner; adjusted PR, 1.25 [95% CI, 1.14-1.38]) or without home ownership (15.9% [95% CI, 14.7%-17.0%] vs 9.3% [95% CI, 8.7%-9.9%] owning their home; adjusted PR, 1.50 [95% CI, 1.34-1.68]) were more likely to have advanced CKM stages compared with their married or home-owning counterparts, respectively. All results remained robust in the sensitivity analyses except for education (eFigure 4 in Supplement 1). Decision trees highlighted employment status and family income to poverty ratio as key SDOH associated with advanced CKM stages in both the main and sensitivity analyses (eFigures 5 and 6 in Supplement 1).

Discussion

This cross-sectional study of a nationally representative sample of US adults showed that individuals with unfavorable SDOH, especially low family income, food insecurity, or unemployment, had a significantly higher likelihood of CKM stages 2 to 4 or advanced CKM stages compared with those with favorable SDOH. Notably, women who were unmarried or not living with a partner or living in a rented home were more likely to have advanced CKM stages, whereas these results were not observed in men. All findings except education remained robust in the sensitivity analyses.

Previous research has extensively documented the association of adverse SDOH with the prevalence and risks of major CKM components, including obesity, diabetes, CVD, and CKD.,,,, In one study, unfavorable SDOH, such as food insecurity, were adversely associated with diabetes self-care behaviors, including checking blood glucose and eating vegetables. In other studies, social disadvantages were associated with more prevalent CVD risk factors and incident CVD., Adverse associations of SDOH with CKD have also been identified. Our findings aligned with these and several other previous studies.,,,,,, Moreover, our study not only confirms that adults with unfavorable SDOH, such as low family income to poverty ratio and food insecurity, were more likely to have CKM stages 2 to 4 and advanced CKM stages but also underscores the need for targeted screening, prevention, and treatment efforts for unemployed adults and those with low income or food insecurity. Unexpectedly, we found that advanced CKM stages were more common in adults who access at least 1 regular health care facility than those without a routine place for health care. This finding contradicts previous studies, possibly due to reverse causality inherent in cross-sectional studies, as individuals with more severe disease may be more likely to seek regular health care services.

In this analysis, we found that adults with 2 or more unfavorable SDOH or with specific unfavorable SDOH (ie, low family income to poverty ratio, food insecurity, government health insurance or lack of health insurance, and unemployment) were more likely to have advanced CKM stages compared with those with fewer than 2 unfavorable SDOHs. These associations differed by sex. Notably, women who were unmarried or not living with a partner or who did not own their home were more likely to have advanced CKM stages, while such associations were not observed in men. Previous studies have highlighted the importance of housing factors in cardiometabolic health and overall well-being.,, For instance, lack of home ownership is a key housing factor associated with not only poor physical health outcomes but also mental health outcomes.,, Moreover, recent studies have indicated that living in a privately rented home was associated with accelerated biological aging, highlighting the substantial health implications of home ownership. However, few studies have explored sex differences in relation to home ownership and CVD or metabolic disease, warranting further investigation in future well-designed studies.

Our findings highlighted important disparities in the prevalence of CKM syndrome across SDOH and sex, emphasizing the importance of screening for and addressing unfavorable SDOHs in the prevention and treatment of CKM syndrome. Specifically, key SDOH, such as low family income, food insecurity, and unemployment, should be prioritized for intervention across the population, while housing factors, such as living in a rented home and not living with a partner, deserve special attention in women. In our study, decision trees were used to estimate which CKM stages and advanced CKM stages are associated with SDOH, identifying employment status and family income as crucial factors. Existing SDOH screening tools, such as Health Leads, IHELP, and WE CARE,,, should be evaluated for their effectiveness in identifying critical factors, such as employment status and family income, in the context of CKM syndrome.

Limitations

This study has several limitations. First, the cross-sectional design limited our ability to establish causal relationships between SDOH and CKM stages. Second, some CVD-related data that were used to define advanced CKM stages, such as cardiac biomarkers, echocardiography, and coronary angiography, were not available in the NHANES database, potentially leading to an underestimation of advanced CKM stages (stages 3 or 4). Third, certain SDOHs, such as social cohesion, structural racism, and neighborhood and community environments, were not assessed due to data limitations. Finally, the applicability of the PREVENT equations was limited to adults aged 30 to 79 years and those without extreme values of CVD risk factors, which may affect the generalizability of our findings.

Conclusions

In this cross-sectional study of a nationally representative sample of US adults, we found statistically significant disparities in the prevalence of CKM stages by SDOH, with notable sex differences. Our findings underscore the disproportionate burden of CKM syndrome among adults with unfavorable SDOH and suggest that addressing these adverse factors might be crucial for the prevention and treatment of CKM syndrome. Specifically, unemployment, low family income, and food insecurity in all adults require targeted attention. Additionally, female individuals who are unmarried or living in a rented home should receive particular attention. Given the limitations, our findings should be interpreted with caution and validated by future studies.

References 44

  1. 1.

    Ndumele CE, Rangaswami J, Chow SL,; American Heart Association. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606-1635

    Not in our library10.1161/cir.0000000000001184

  2. 2.

    Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US Adults, 2011-2020. JAMA. 2024;331(21):1858-1860

    Not in our library10.1001/jama.2024.6892

  3. 3.

    Jilani MH, Javed Z, Yahya T,. Social determinants of health and cardiovascular disease: current state and future directions towards healthcare equity. Curr Atheroscler Rep. 2021;23(9):55

    Not in our library10.1007/s11883-021-00949-w

  4. 4.

    Gómez CA, Kleinman DV, Pronk N,. Addressing health equity and social determinants of health through Healthy People 2030. J Public Health Manag Pract. 2021;27(suppl 6):S249-S257

    Not in our library10.1097/phh.0000000000001297

  5. 5.

    San Diego ERN, West NT, Pichon LC,. Associations between sociodemographic variables, social determinants of health, and diabetes: findings from a congregational health needs assessment. Am J Health Promot. 2024;38(6):809-819

    Not in our library10.1177/08901171241234662

  6. 6.

    Chang R, Philip J, Javed U,. Unfavorable social determinants of health and risk of mortality in adults with diabetes: findings from the National Health Interview Survey. BMJ Open Diabetes Res Care. 2024;12(1):e003710

    Not in our library10.1136/bmjdrc-2023-003710

  7. 7.

    Hundemer GL, Ravani P, Sood MM,. Social determinants of health and the transition from advanced chronic kidney disease to kidney failure. Nephrol Dial Transplant. 2023;38(7):1682-1690

    Not in our library10.1093/ndt/gfac302

  8. 8.

    Ozieh MN, Garacci E, Walker RJ, Palatnik A, Egede LE. The cumulative impact of social determinants of health factors on mortality in adults with diabetes and chronic kidney disease. BMC Nephrol. 2021;22(1):76

    Not in our library10.1186/s12882-021-02277-2

  9. 9.

    NHANES questionnaires, datasets, and related documentation. Centers for Disease Control and Prevention. Accessed May 25, 2024. https://wwwn.cdc.gov/nchs/nhanes/Default.aspx

    Not in our library

  10. 10.

    Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(suppl 4):S117-S314

    Not in our library10.1016/j.kint.2023.10.018

  11. 11.

    Khan SS, Matsushita K, Sang Y,. Development and validation of the American Heart Association’s PREVENT equations. Circulation. 2024;149(6):430-449

    Not in our library10.1161/circulationaha.123.067626

  12. 12.

    Inker LA, Eneanya ND, Coresh J,; Chronic Kidney Disease Epidemiology Collaboration. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737-1749

    Not in our library10.1056/nejmoa2102953

  13. 13.
  14. 14.

    Va P, Dodd KW, Zhao L,. Evaluation of measurement error in 24-hour dietary recall for assessing sodium and potassium intake among US adults - National Health and Nutrition Examination Survey (NHANES), 2014. Am J Clin Nutr. 2019;109(6):1672-1682

    Not in our library10.1093/ajcn/nqz044

  15. 15.

    Murakami K, Livingstone MB. Prevalence and characteristics of misreporting of energy intake in US adults: NHANES 2003-2012. Br J Nutr. 2015;114(8):1294-1303

    Not in our library10.1017/s0007114515002706

  16. 16.

    Li C, Ford ES, Zhao G, Wen XJ, Gotway CA. Age adjustment of diabetes prevalence: use of 2010 U.S. Census data. J Diabetes. 2014;6(5):451-461

    Not in our library10.1111/1753-0407.12122

  17. 17.

    Summary file 1 dataset. US Census Bureau. Accessed June 15, 2024. https://www.census.gov/data/datasets/2010/dec/summary-file-1.html

    Not in our library

  18. 18.

    Coutinho LM, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Rev Saude Publica. 2008;42(6):992-998

    Not in our library10.1590/s0034-89102008000600003

  19. 19.

    Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21

    Not in our library10.1186/1471-2288-3-21

  20. 20.

    Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706

    Not in our library10.1093/aje/kwh090

  21. 21.

    Cao J, Zhang S. Multiple comparison procedures. JAMA. 2014;312(5):543-544

    Not in our library10.1001/jama.2014.9440

  22. 22.

    Bender R, Lange S. Adjusting for multiple testing–when and how? J Clin Epidemiol. 2001;54(4):343-349

    Not in our library10.1016/s0895-4356(00)00314-0

  23. 23.

    Wang JS, Xia PF, Ma MN,. Trends in the prevalence of metabolically healthy obesity among US adults, 1999-2018. JAMA Netw Open. 2023;6(3):e232145

    Not in our library10.1001/jamanetworkopen.2023.2145

  24. 24.

    Hill-Briggs F, Adler NE, Berkowitz SA,. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020;44(1):258-279

    Not in our library10.2337/dci20-0053

  25. 25.

    Javed Z, Valero-Elizondo J, Maqsood MH,. Social determinants of health and obesity: findings from a national study of US adults. Obesity (Silver Spring). 2022;30(2):491-502

    Not in our library10.1002/oby.23336

  26. 26.

    Acquah I, Hagan K, Javed Z,. Social determinants of cardiovascular risk, subclinical cardiovascular disease, and cardiovascular events. J Am Heart Assoc. 2023;12(6):e025581

    Not in our library10.1161/jaha.122.025581

  27. 27.

    Powell-Wiley TM, Baumer Y, Baah FO,. Social determinants of cardiovascular disease. Circ Res. 2022;130(5):782-799

    Not in our library10.1161/circresaha.121.319811

  28. 28.

    Hall YN. Social determinants of health: addressing unmet needs in nephrology. Am J Kidney Dis. 2018;72(4):582-591

    Not in our library10.1053/j.ajkd.2017.12.016

  29. 29.

    Burch AE, Elliott SK, Harris ST. Associations between social determinants of health and diabetes self-care behaviors among insured adult patients. Diabetes Res Clin Pract. 2024;207:111048

    Not in our library10.1016/j.diabres.2023.111048

  30. 30.

    Cathro CJ, Brenn T, Chen SLF. Education level and self-reported cardiovascular disease in Norway-the Tromsø Study, 1994-2016. Int J Environ Res Public Health. 2023;20(11):5958

    Not in our library10.3390/ijerph20115958

  31. 31.

    Che B, Shen S, Zhu Z,. Education level and long-term mortality, recurrent stroke, and cardiovascular events in patients with ischemic stroke. J Am Heart Assoc. 2020;9(16):e016671

    Not in our library10.1161/jaha.120.016671

  32. 32.

    Hu M, Yang T, Yang Y. Causal associations of education level with cardiovascular diseases, cardiovascular biomarkers, and socioeconomic factors. Am J Cardiol. 2024;213:76-85

    Not in our library10.1016/j.amjcard.2023.06.044

  33. 33.

    Odutayo A, Gill P, Shepherd S,. Income disparities in absolute cardiovascular risk and cardiovascular risk factors in the United States, 1999-2014. JAMA Cardiol. 2017;2(7):782-790

    Not in our library10.1001/jamacardio.2017.1658

  34. 34.

    Park YM, Baek JH, Lee HS,. Income variability and incident cardiovascular disease in diabetes: a population-based cohort study. Eur Heart J. 2024;45(21):1920-1933

    Not in our library10.1093/eurheartj/ehae132

  35. 35.

    Brandt EJ, Chang T, Leung C, Ayanian JZ, Nallamothu BK. Food insecurity among individuals with cardiovascular disease and cardiometabolic risk factors across race and ethnicity in 1999-2018. JAMA Cardiol. 2022;7(12):1218-1226

    Not in our library10.1001/jamacardio.2022.3729

  36. 36.

    Leung CW, Wolfson JA, Brandt EJ, Rimm EB. Disparities in cardiovascular health by food security status and supplemental nutrition assistance program participation using Life’s Essential 8 metrics. JAMA Netw Open. 2023;6(6):e2321375

    Not in our library10.1001/jamanetworkopen.2023.21375

  37. 37.

    Sims M, Kershaw KN, Breathett K,; American Heart Association Council on Epidemiology and Prevention and Council on Quality of Care and Outcomes Research. Importance of housing and cardiovascular health and well-being: a scientific statement from the American Heart Association. Circ Cardiovasc Qual Outcomes. 2020;13(8):e000089

    Not in our library10.1161/hcq.0000000000000089

  38. 38.

    Howden-Chapman P, Bennett J, Edwards R, Jacobs D, Nathan K, Ormandy D. Review of the impact of housing quality on inequalities in health and well-being. Annu Rev Public Health. 2023;44:233-254

    Not in our library10.1146/annurev-publhealth-071521-111836

  39. 39.

    Alidoust S, Huang W. A decade of research on housing and health: a systematic literature review. Rev Environ Health. 2021;38(1):45-64

    Not in our library10.1515/reveh-2021-0121

  40. 40.

    Ettman CK, Cohen GH, Vivier PM, Galea S. Savings, home ownership, and depression in low-income US adults. Soc Psychiatry Psychiatr Epidemiol. 2021;56(7):1211-1219

    Not in our library10.1007/s00127-020-01973-y

All 44 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.